Egypt is due to receive a second batch of Johnson & Johnson vaccine on Saturday, the Egyptian Authority for Unified Procurement (AUP) said in a brief statement on Thursday.
The shipment will compromise 525,600 shots of the single-dose vaccine, according to the AUP, which is responsible for the country's purchase orders.
This comes within the framework of Egypt’s plan to “provide anti-coronavirus vaccines and vaccines for travelers and all Egyptian people," the statement added.
Egypt contracted with the African Export-Import Bank in May to import 20 million Johnson & Johnson vaccine doses. The first batch, comprised of 261,000 doses, arrived in August.
Egypt, which has recorded a total of 288,732 cases and 16,743 deaths, is currently ramping up efforts to vaccinate as many people as possible as a fourth wave of infections is expected later in September.
Millions of Sinopharm, Sinovac, Sputnik, and AstraZeneca vaccine doses have arrived recently and more shots are expected shortly.
Egypt started locally manufacturing the Sinovac coronavirus vaccine in June and distributed the first batch of the product in late-August, with around 15 to 18.5 million doses expected to be produced per month.
The local production of the WHO-approved Sinovac — which was granted an emergency use license by the Egyptian Drug Authority (EDA) on 23 August — is part of an agreement signed between the Egyptian Holding Company for Biological Products and Vaccines (VACSERA) and the Chinese biopharmaceutical company Sinovac.
According to the World Health Organisation, 8,741,005 vaccine doses have been administered in Egypt.